2019 | | 2019 ARIA Care pathways for allergen immunotherapy | 박해심 |
2002 | | A case of bronchial asthma due to cefadroxil in a housewife | 남동호, 박해심, 서유진, 서창희, 정재욱, 최정희 |
1999 | | A case of intravenous immunoglobulin therapy in severe aspirin-sensitive asthma patient combined with IgG1 and IgG3 subclass deficiency | 남동호, 박해심 |
2002 | | A case of mint flavor-induced anaphylaxis in an asthmatic patient | 김선신, 남동호, 박해심, 서유진 |
2022 | | A pilot investigation of e-cigarette use and smoking behaviour among patients with chronic airway disease or respiratory symptoms | 박주헌 |
2018 | | A Randomized, Multicenter, Double-blind, Phase III Study to Evaluate the Efficacy on Allergic Rhinitis and Safety of a Combination Therapy of Montelukast and Levocetirizine in Patients With Asthma and Allergic Rhinitis | 박해심 |
2013 | | A survey of the prescription patterns of allergen immunotherapy in Korea. | 남동호 |
2021 | | Administration of vitamin E attenuates airway inflammation through restoration of Nrf2 in a mouse model of asthma | 박해심, 신유섭 |
2020 | | Allergic disorders and susceptibility to and severity of COVID-19: A nationwide cohort study | 유슬기 |
2019 | | Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology | 박해심 |
2008 | | Analysis of the Repeated Measurement Data using the Hierarchical Clustering and Nonlinear Regression Methods in Asthma Pharmacogenetic Study | 박해심, 이현영 |
2021 | | ARIA digital anamorphosis: Digital transformation of health and care in airway diseases from research to practice | 박해심 |
2021 | | ARIA-EAACI care pathways for allergen immunotherapy in respiratory allergy | 박해심 |
2024 | | Cannabinoid receptor 2 as a regulator of inflammation induced oleoylethanolamide in eosinophilic asthma | 박해심, 신유섭, 예영민 |
2020 | | Ceramide/sphingosine-1-phosphate imbalance is associated with distinct inflammatory phenotypes of uncontrolled asthma | 김승현, 박해심 |
2022 | | Contribution of dipeptidyl peptidase 10 to airway dysfunction in patients with NSAID-exacerbated respiratory disease | 박해심, 신유섭, 최영우 |
2023 | | Current Issues in the Management of IgG Subclass Deficiencies in Adults With Chronic Respiratory Diseases | 박해심, 장재혁 |
2019 | | Diagnosis and management of NSAID-Exacerbated Respiratory Disease (N-ERD)-a EAACI position paper | 박해심 |
2022 | | Down-regulated surfactant protein B in obese asthmatics | 김승현, 박해심 |
2020 | | Dupilumab Efficacy in Patients Stratified by Baseline Treatment Intensity and Lung Function | 박해심 |
2007 | | Effect of Cysteinyl Leukotriene D4 on Chemokine Expression via Cysteinyl Leukotriene Receptor 1 in Human Lung Epithelial Cells, A549 | 김설화, 박해심 |
1998 | | Elevation of specific immunoglobulin A antibodies to both allergen and bacterial antigen in induced sputum from asthmatics. | 남동호, 박해심 |
2022 | | Emerging Biomarkers Beyond Leukotrienes for the Management of Nonsteroidal Anti-inflammatory Drug (NSAID)-Exacerbated Respiratory Disease | 박해심 |
2019 | | Evaluation of Neutrophil Activation Status According to the Phenotypes of Adult Asthma | 김승현, 박해심 |
2022 | | Extracellular Traps: A Novel Therapeutic Target for Severe Asthma | 박해심, 최영우 |
2022 | | Immunoregulatory effects of Lactococcus lactis-derived extracellular vesicles in allergic asthma | 박해심, 신유섭, 최영우 |
2023 | | KAAACI Allergic Rhinitis Guidelines: Part 1. Update in Pharmacotherapy | 박도양 |
2003 | | Leukotriene related gene polymorphisms in ASA-intolerant asthma: an association of 5-lipoxygenase haplotype | 박해심, 서유진, 신승수, 최정희 |
2020 | | Lung Disease Diagnostic Model Through IgG Sensitization to Microbial Extracellular Vesicles | 최영우 |
2020 | | Management of Allergic Patients During the COVID-19 Pandemic in Asia | 박해심, 이영수 |
2020 | | Metabolic shift favoring C18:0 ceramide accumulation in obese asthma | 김승현, 박해심, 최영우 |
2023 | | Nasal Transcriptome and Epigenome Analysis Identifies the Pathogenic Features of Aspirin-Exacerbated Respiratory Disease | 박해심, 예영민 |
2021 | | New phenotyping of severe asthmatics using long-term followed measurement data | 박래웅, 박유진 |
2020 | | NSAID-Exacerbated Respiratory Disease (NERD): From Pathogenesis to Improved Care | 박해심, 우성대 |
2021 | | Pharmacogenomics of Hypersensitivity to Non-steroidal Anti-inflammatory Drugs | 박해심 |
2010 | | Probable Role of Beta 2-Adrenergic Receptor Gene Haplotype in Toluene Diisocyanate-Induced Asthma | 김승현, 박해심, 예영민 |
2015 | | Progress and Prospect: A Bibliometric Analysis of Research Papers by Korean Allergists Over Recent Five Years (2009-2013). | 예영민 |
2019 | | Real-life effectiveness of inhaler device switch from dry powder inhalers to pressurized metred-dose inhalers in patients with asthma treated with ICS/LABA | 박해심, 윤덕용 |
2014 | | Reference ranges and determinant factors for exhaled nitric oxide in a healthy korean elderly population | 박해심, 조남한 |
1998 | | Revival of Hop Japanese pollinosis in asthmatic subjects in Kyungki area | 남동호, 박해심 |
2023 | | Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA-MeDALL hypothesis | 박해심 |
2023 | | Role of club cell 16-kDa secretory protein in asthmatic airways | 박해심 |
2019 | | Serum Levels of Eosinophil-Derived Neurotoxin: A Biomarker for Asthma Severity in Adult Asthmatics | 박해심, 이영수 |
2005 | | Serum Specific IgG to Cytokeratin : A Useful Serologic Marker for Toluene Diisocyanate-Induced Asthma | 박해심, 예영민 |
2023 | | The effect of apigenin, an aryl hydrocarbon receptor antagonist, in Phthalate-Exacerbated eosinophilic asthma model | 박해심, 신유섭 |
2022 | | The Role of Di(2-Ethylhexyl) Phthalate as an Exacerbating Factor in Chronic Spontaneous Urticaria | 박해심, 신유섭 |
2019 | | The synergistic effects of clopidogrel with montelukast may be beneficial for asthma treatment | 박해심, 신유섭 |
2001 | | Trichophyton and asthma : specific IgE, IgG1 and IgG4 determination | 김선신, 남동호, 박해심 |
2013 | | Unraveling the genetic basis of aspirin hypersensitivity in asthma beyond arachidonate pathways. | 박해심 |
2020 | | Update on the Management of Nonsteroidal Anti-Inflammatory Drug Hypersensitivity | 박해심 |